ISPOR 21ST ANNUAL INTERNATIONAL MEETING ISSUE PANEL CONSIDERS MCDA AS A POSSIBLE NEW PARADIGM IN HEALTH CARE DECISION MAKING

Published May 24, 2016
Washington, DC—May 24, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 21st Annual International Meeting Issue Panel 12—Multi-Criteria Decision Analysis: A New Paradigm in Health Care Decision Making? What Are the Current Status, Challenges, and Opportunities?—was held this afternoon in Washington, DC, USA. The Issue Panel moderator was James Dolan, MD, Professor, University of Rochester, Rochester, NY, USA. Panelists included:
  • Kevin Marsh, PhD, Executive Director, Evidera, London, UK
  • Mireille M. Goetghebeur, PhD, MEng, Global Scientist, LASER Analytica and School of Public Health, University of Montreal, Montreal, QC, Canada
  • Mabel Moreno Viscaya, PhD, Senior Economist, Instituto de Evaluación Tecnológica en Salud (IETS), Bogata, Colombia
Multiple criteria decision analysis (MCDA), an application of decision analytics that can help improve the quality of complicated decisions, is gaining significant interest in health care. MCDA application in health care decision making can also be subject to controversy. For example, while many MCDA methods are available, little guidance currently exists for how to choose the right technique for a particular problem. The ISPOR Multi-Criteria Decision Analysis in Health Care Decision Making Emerging Good Practices Task Force was established in 2014 to help fill this knowledge gap. The panel used content from a two-day workshop that convened MCDA experts from around the world to illustrate and spark discussion of the controversies and complexities of health care decisions. The panelists encouraged attendees to apply MCDA in health economics and outcomes research to provide a way to change the current paradigm in health care decision making. Additional information and resources on MCDA can be found on the ISPOR website, including: Presentations and slide decks from the ISPOR 21st Annual International meeting can be found here. Interested parties can follow news and developments from the meeting on social media using the hashtag #ISPORDC.

###

Related Stories

ISPOR Chief Science Officer Dr Laura Pizzi Named to NJBIZ's 2026 People to Watch in Healthcare List

Jul 29, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) is proud to announce its Chief Science Officer, Laura Pizzi, PharmD, MPH, has been recognized by NJBIZ as one of its 2026 People to Watch in Healthcare.

ISPOR Publishes White Paper Focused on Systemic Coherence for Healthcare Decision Making in Europe

Jul 21, 2026

ISPOR—The Professional Society for Health Economics and Outcomes Research announced that it has released a new white paper, “Achieving Systemic Coherence for Healthcare Decision Making in Europe.”
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×